Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
about
Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causationSystematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosisEnvironmental risk factors for multiple sclerosis: a review with a focus on molecular mechanismsEpstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapyEnvironmental effects of ozone depletion and its interactions with climate change: progress report, 2011Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosisVitamin D and multiple sclerosis: epidemiology, immunology, and genetics.Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.CCSVI is associated with multiple sclerosis.Supplementation and therapeutic use of vitamin D in patients with multiple sclerosis: consensus of the Scientific Department of Neuroimmunology of the Brazilian Academy of Neurology.Biomarker studies in multiple sclerosis: from proteins to noncoding RNAs.Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.Validation of Sun Exposure Reported Annually Against Interim Self-report and Daily Sun Diaries.EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis.Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: A multiethnic study.Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.Higher incidence of Epstein-Barr virus-induced lymphocyte transformation in multiple sclerosis.Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.Early-life hygiene-related factors affect risk of central nervous system demyelination and asthma differentially.Epstein-Barr virus genotypes and strains in central nervous system demyelinating disease and Epstein-Barr virus-related illnesses in Australia.Epstein-Barr virus, latitude and multiple sclerosis.
P2860
Q26830464-EDF29770-2CC3-4DDF-A03B-8185CB6BBBF1Q26852295-6327E858-E1B2-4B22-965F-B77230009DBEQ27006548-3CE8C8B7-B2DB-472B-8229-174E9B408440Q30878158-236FE446-9A13-4B69-914B-37322CD9CC7EQ34141848-472E071A-33C4-463A-85D8-DB94A10F6F9BQ35144996-187241D5-DE60-477B-8172-BF15615F0528Q35956144-6E462CFB-8950-4351-B6BF-27A535702AFEQ36339988-4FF45BE5-8B43-4410-8CC5-78A1A28D8D29Q36638670-C9C9691A-7D2A-4D53-909E-9F68AD550344Q36751056-CC99F0CD-785A-4002-B0B2-C883984F97D2Q36881292-B18DFFDD-847C-4714-A3C8-B312A2AED93BQ37956299-72A1AD81-9D09-4858-BE6F-2CE6574BD3D6Q38042767-C7AC44D5-87C1-4C95-B5E0-884BF9A70ED8Q38194076-B73D4EB6-D903-4992-A3F0-222900D46D04Q38234717-F425EEA5-1525-4033-B2DB-5886E8C09085Q38616570-16D83B27-A5F9-4513-BF47-2B6C99E9FDF9Q38825421-205F2431-8754-42DE-81F1-E5510F52B64BQ39127398-F0F4AAC8-B5B5-49FB-AD98-FE0482F2BED3Q40050869-C9C3B628-CD13-4EB4-A69B-A3FBEC354B6CQ40064312-16CD280A-4655-4102-92A7-B5BD9F5B684FQ41705617-B2C9F050-E96D-4FA6-A127-8E042F7E7D5BQ42227948-44C55E60-D8DC-446D-BBD9-E8B080E1A979Q42253738-55CCD06D-1C0E-4D82-8159-739F93AA06D2Q42274843-52A436D2-C5D8-44AC-8C12-68A95C6857F1Q44201611-97BDCC37-FAE7-4836-8840-6C4F58A940EEQ44757734-D1D1B4CF-E2C7-4A68-B739-3FF891C47A1FQ45356350-0AE4B2C5-4D59-4B41-A6BF-795408409FC4
P2860
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
@en
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
@nl
type
label
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
@en
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
@nl
prefLabel
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
@en
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
@nl
P2093
P1433
P1476
Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
@en
P2093
A J McMichael
A-L Ponsonby
B V Taylor
D Williams
I A F van der Mei
J M Burrows
M P Pender
P304
P356
10.1212/WNL.0B013E318227062A
P407
P577
2011-07-13T00:00:00Z